Reactive oxygen species is mediators of cardiac injury and protection: The relevance to anesthesia practice

Anesthesia and Analgesia

Volumn 101, Issue 5, 2005, Pages 1275-1287

  Kevin, Leo G ^b   Novalija, Enis ^b   Stowe, David F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; ALPHA TOCOPHEROL; AMOBARBITAL; ANESTHETIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DEFEROXAMINE; ENFLURANE; ETOMIDATE; FREE RADICAL; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; MANNITOL; METHOHEXITAL; MIDAZOLAM; PARACETAMOL; PENTOBARBITAL; PROPOFOL; REACTIVE OXYGEN METABOLITE; SEVOFLURANE; SUPEROXIDE DISMUTASE; THIOPENTAL;

APOPTOSIS; CLINICAL TRIAL; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INJURY; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; STUNNED HEART MUSCLE;

EID: 27444444994     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000180999.81013.D0     Document Type: Review

References (131)

1. Vanden Hoek TL, Li C, Shao Z, et al. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 1997;29:2571-83.
2. 2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2002;283:H566-74.
3. Kevin LG, Novalija E, Riess ML, et al. Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg 2003;96:949-55.
4. Rouquette M, Page S, Bryant R, et al. Xanthine oxidoreductase is asymmetrically localised on the outer surface of human endothelial and epithelial cells in culture. FEBS Lett 1998;426:397-401.
5. Kawahito K, Kobayashi E, Ohmori M, et al. Enhanced responsiveness of circulatory neutrophils after cardiopulmonary bypass: increased aggregability and superoxide producing capacity. Artif Organs 2000;24:37-42.
6. Clermont G, Vergely C, Jazayeri S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology 2002;96:80-7.
7. Guzik T, Mussa S, Gastaldi D, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002;105:1656-62.
8. Kojda G, Kottenberg K. Regulation of basal myocardial function by NO. Cardiovasc Res 1999;41514-23.
9. Novalija E, Varadarajan SG, Camara AKS, et al. Anesthetic preconditioning: Triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol 2002;283:H44-52.
10. Mungrue I, Gros R, You X, et al. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest 2002;109:735-43.
11. Brodsky S, Gao S, Li H, Goligorsky M. Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol Heart Circ Physiol 2002;283:H2130-9.
12. McColl AJ, Keeble T, Hadjinikolaou L, et al. Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem 1998;35:616-23.
13. Kloner RA, Przyklenk K, Kay GL. Clinical evidence for stunned myocardium after coronary artery bypass surgery. J Card Surg 1994;9:397-402.
14. Chang PP, Sussman MS, Conte JV, et al. Postoperative ventricular function and cardiac enzymes after on-pump versus off-pump CABG surgery. Am J Cardiol 2002;89:1107-10.
15. Bolli R, Patel BS, Jeroudi MO, et al. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest 1988;82:476-85.
16. Maulik N, Yoshida T, Das DK. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic Biol Med 1998;24:869-75.
17. Tavazzi B, Di Pierro D, Bartolini M, et al. Lipid peroxidation, tissue necrosis, and metabolic and mechanical recovery of isolated reperfused rat heart as a function of increasing ischemia. Free Radic Res 1998;28:25-37.
18. Nakaya H, Tohse N, Kanno M. Electrophysiological derangements induced by lipid peroxidation in cardiac tissue. Am J Physiol 1987;253:H1089-97.
19. Dhein S, Schott M, Gottwald E, et al. The contribution of neutrophils to reperfusion arrhythmias and a possible role for antiadhesive pharmacological substances. Cardiovasc Res 1995;30:881-8.
20. Marczin N, El-Habashi N, Royston D. Free radicals and cardiac arrhythmias following coronary surgery: actors of the drama or bystanders of the spectacle. Acta Anaesthesiol Scand 2003;47:639-42.
21. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996;28:506-14.
22. Blaustein AS, Schine L, Brooks WW, et al. Influence of exogenously generated oxidant species on myocardial function. Am J Physiol 1986;250:H595-9.
23. Habib FM, Springall DR, Davies GJ, et al. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyophathy. Lancet 1996;347:1151-5.
24. Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997;96:2414-20.
25. Kaneko M, Lee SL, Wolf CM, Dhalla NS. Reduction of calcium channel antagonist binding sites by oxygen free radicals in rat heart. J Mol Cell Cardiol 1989;21:935-43.
26. Kaneko M, Chapman DC, Ganguly PK, et al. Modification of calcium adrenergic receptors by oxygen free radicals. Am J Physiol 1991;260:H821-6.
27. Ide T, Tsutsui H, Hayashidani S, et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 2001;88:529-35.
28. McMurray J, Chopra M, Abdullah I, et al. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 1993;14:1493-8.
29. Nishiyama Y, Ikeda H, Haramaki N, et al. Oxidative stress is related to exercise tolerance in patients with heart failure. Am Heart J 1998;135:115-20.
30. Burlacu A, Jinga V, Gafencu AV, Simionescu M. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell Tissue Res 2001;306:409-16.
31. Li PF, Dietz R, von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 1997;96:3602-9.
32. Rajagopalan S, Meng XP, Ramasamy S, et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2579-9.
33. Shi Y, Niculescu R, Wang D, et al. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol 2001;21:739-45.
34. Azevedo LC, Pedro MA, Souza LC, et al. Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc Res 2000;47:436-45.
35. Mittal CK, Murad F. Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3′,5′-monophosphate formation. Proc Natl Acad Sci U S A 1977;74:4360-4.
36. 2 and phosphorylation of 30 kilodalton proteins as early responses of cell cycle-dependent inhibition of DNA synthesis by transforming growth factor beta 1. Cell Growth Differ 1991;2:583-91.
37. Sauer H, Rahimi G, Hescheler J, Wartenberg M. Effects of electrical fields on cardiomyocyte differentiation of embryonic stem cells. J Cell Biochem 1999;75:710-23.
38. Prabhakar NR. Oxygen sensing by the carotid body chemoreceptors. J Appl Physiol 2000;88:2287-95.
39. Neumcke I, Schneider B, Fandrey J, Pagel H. Effects of pro- and antioxidative compounds on renal production of erythropoietin. Endocrinology 1999;140:641-5.
40. 2-dependent degredation domain via the ubiquitin-proteosome pathway. Proc Natl Acad Sci U S A 1990;95:7987-92.
41. Wolin MS, Burke-Wolin TM, Mohazzab-H KM. Roles for NAD(P)H oxidases and reactive oxygen species in vascular sensing mechanisms. Respir Physiol 1999;115:229-38.
42. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991;10:2247-58.
43. Napoli C, de Nigris F, Palinski W. Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem 2001;82:674-82.
44. Kilgore KS, Friedrichs GS, Johnson CR, et al. Protective effects of the SOD-mimetic SC-52608 against ischemia/reperfusion damage in the rabbit isolated heart. J Mol Cell Cardiol 1994;26:995-1006.
45. Li Q, Bolli R, Qiu Y, et al. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 2001;103:1893-8.
46. Murohara Y, Yui Y, Hattori R, Kawai C. Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction. Am J Cardiol 1991;67:765-7.
47. Flaherty JT, Pitt B, Gruber JW, et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 1994;89:1982-91.
48. Tsao C, Greene P, Odlind B, Brater D. Pharmacokinetics of recombinant human superoxide dismutase in healthy volunteers. Clin Pharmacol Ther 1991;50:713-20.
49. Ihnat P, Vennerstrom J, Robinson D. Synthesis and solution properties of deferoxamine amides. J Pharm Sci 2000;89:1525-36.
50. Ambrosio G, Zweier JL, Jacobus WE, et al. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 1987;76:906-15.
51. Bolli R, Patel BS, Zhu WX, et al. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. Am J Physiol 1987;253:H1372-80.
52. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals: studies with "anti-free radical" interventions and a free radical- generating system in the isolated perfused rat heart. Circ Res 1986;58:331-40.
53. Ferreira R, Burgos M, Milei J, et al. Effect of supplementing cardioplegic solution with deferoxamine on reperfused human myocardium. J Thorac Cardiovasc Surg 1990;100:708-14.
54. Drossos G, Lazou A, Panagopoulos P, Westaby S. Deferoxamine cardioplegia reduces superoxide radical production in human myocardium. Ann Thorac Surg 1995;59:169-72.
55. Engl M, Cavarocchi N, O'Brien J et al. Influence of antioxidants (mannitol and allopurinol) on oxygen free radical generation during and after cardiopulmonary bypass. Circulation 1986;74:III134-7.
56. Larsen M, Webb G, Kennington S, et al. Mannitol in cardioplegia as an oxygen free radical scavenger measured by malondialdehyde. Perfusion 2002;17:51-5.
57. Akizuki S, Yoshida S, Chambers DE, et al. Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts. Cardiovasc Res 1985;19:686-92.
58. Nielsen VG, Tan S, Baird MS, et al. Xanthine oxidase mediates myocardial injury after hepatoenteric ischemia-reperfusion. Crit Care Med 1997;25:1044-50.
59. Johnson W, Kayser K, Brenowitz J, Saedi S. A randomized controlled trial of allopurinol in coronary bypass surgery. Am Heart J 1991;121:20-4.
60. Merrill G, McConnell P, Vandyke K, Powell S. Coronary and myocardial effects of acetaminophen: protection during ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2001;280: H2631-8.
61. Merrill GF. Acetaminophen and low-flow myocardial ischemia: efficacy and antioxidant mechanisms. Am J Physiol Heart Circ Physiol 2002;282:H1341-9.
62. Massey KD, Burton KP. alpha-Tocopherol attenuates myocardial membrane-related alterations resulting from ischemia and reperfusion. Am J Physiol 1989;256:H1192-9.
63. Dingchao H, Zhiduan Q, Liye H, Xiaodong F. The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg 1994;42:276-8.
64. Yau TM, Weisel RD, Mickle DA, et al. Vitamin E for coronary bypass operations: a prospective, double-blind, randomized trial. J Thorac Cardiovasc Surg 1994;108:302-10.
65. Sisto T, Paajanen H, Metsa-Ketela T, et al. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thorac Surg 1995;59:1519-23.
66. Lassnigg A, Punz A, Barker R, et al. Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study. Br J Anaesth 2003;90:148-54.
67. Westhuyzen J, Cochrane AD, Tesar PJ, et al. Effect of preoperative supplementation with alpha-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1997;113:942-8.
68. The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000;342:154-60.
69. Vivekananthan DP, Penn MS, Sapp SK, et al. Use of antioxidant vitamins for the prevention of cardiovascular diseases: a meta-analysis of randomised trials. Lancet 2003;361:2017-23.
70. Forman MB, Puett DW, Cates CU, et al. Glutathione redox pathway and reperfusion injury: effect of N-acetylcysteine on infarct size and ventricular function. Circulation 1988;78:202-13.
71. Andersen LW, Thiis J, Kharazmi A, Rygg I. The role of N-acetylcystein administration on the oxidative response of neutrophus during cardiopulmonary bypass. Perfusion 1995;10:21-6.
72. Arstall MA, Yang J, Stafford I, et al. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction: safety and biochemical effects. Circulation 1995;92:2855-62.
73. Hallett MB, Shandall A, Young HL. Mechanism of protection against "reperfusion injury" by aprotinin: roles of polymorphonuclear leucocytes and oxygen radicals. Biochem Pharmacol 1985;34:1757-61.
74. McCarthy R, Tuman KJ, O'Connor C, Ivankovich AD. Aprotinin pretreatment diminishes postischemic myocardial contractile dysfunction in dogs. Anesth Analg 1999;89:1096-100.
75. Wendel HP, Heller W, Michel J, et al. Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage. J Thorac Cardiovasc Surg 1995;109:1164-72.
76. Di Salvo C, Louca LL, Pattichis K, et al. Does activated neutrophil depletion on bypass by leukocyte filtration reduce myocardial damage? A preliminary report. J Cardiovasc Surg 1996;37:93-100.
77. Bozdayi M, Borowiec J, Nilsson L, et al. Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery. Artif Organs 1996;20:1008-16.
78. Borowiec JW, Venge P, Henze A, et al. Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin coated and uncoated circuits. Thoracic Cardiovasc Surg 1997;45:295-301.
79. Valen G, Kawakami T, Tahepold P, et al. Glucocorticoid pre-treatment protects cardiac function and induces cardiac heat shock protein 72. Am J Physiol Heart Circ Physiol 2000;279:H836-43.
80. Pearl JM, Nelson DP, Schwartz SM, et al. Glucocorticoids reduce ischemia-reperfusion-induced myocardial apoptosis in immature hearts. Ann Thorac Surg 2002;74:830-6.
81. Kahraman S, Demiryurek AT. Propofol is a peroxynitrite scavenger. Anesth Analg 1997;84:1127-9.
82. Young Y, Menon D, Tisavipat N, et al. Propofol neuroprotection in a rat model of ischaemia reperfusion injury. Eur J Anaesthesiol 1997;14:320-6.
83. Navapurkar V, Skepper J, Jones J, Menon D. Propofol preserves the viability of isolated rat hepatocyte suspensions under an oxidant stress. Anesth Analg 1998;87:1152-7.
84. Kokita N, Hara A. Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart. Anesthesiology 1996;84:117-27.
85. Kokita N, Hara A, Abiko Y, et al. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg 1998;86:252-8.
86. Buljubasic N, Marijic J, Berczi V, et al. Differential effects of etomidate, propofol, and midazolam on calcium and potassium channel currents in canine myocardial cells. Anesthesiology 1996;85:1092-9.
87. Sztark F, Ichas F, Ouhabi R, et al. Effects of the anaesthetic propofol on the calcium-induced permeability transition of rat heart mitochondria: direct pore inhibition and shift of the gating potential. FEBS Lett 1995;368:101-4.
88. Kowaltowski A, Castilho RF, Vercesi AE. Mitochondrial permeability transition and oxidative stress. FEBS Lett 2001;495:12-5.
89. Ebel D, Schlack W, Comfere T, et al. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart. Br J Anaesth 1999;83:903-8.
90. Aldemir O, Celebi H, Cevik C, Duzgun E. The effects of propofol or halothane on free radical production after tourniquet induced ischaemia-reperfusion injury during knee arthroplasty. Acta Anaesthesiol Scand 2001;45:1221-5.
91. De La Cruz JP, Zanca A, Carmona JA, de la Cuesta FS. The effect of propofol on oxidative stress in platelets from surgical patients. Anesth Analg 1999;89:1050-5.
92. Sayin MM, Ozatamer O, Tasoz R, et al. Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery. Br J Anaesth 2002;89:242-6.
93. Smith DS, Rehncrona S, Westerberg E, et al. Lipid peroxidation in brain tissue in vitro: antioxidant effects of barbiturates. Acta Physiol Scand 1979;105:527-9.
94. Cole DJ, Cross LM, Drummond JC, et al. Thiopentone and methohexital, but not pentobarbitone, reduce early focal cerebral ischemic injury in rats. Can J Anaesth 2001;48:807-14.
95. Weiss M, Buhl R, Birkhahn A, et al. Do barbiturates and their solutions suppress FMLP-induced neutrophil chemiluminescence? Eur J Anaesthesiol 1994;11:371-9.
96. Dalsing MC, Sieber P, Grosfeld JL, et al. Ischemic bowel: the protective effect of free-radical anion scavengers. J Pediatr Surg 1983;18:360-4.
97. Tamaki F, Oguchi T, Kashimoto S, et al. Effects of propofol on ischemia and reperfusion in the isolated rat heart compared with thiamylal. Jpn Heart J 2001;42:193-206.
98. Krumholz W, Demel C, Jung S, et al. The effects of thiopentone, etomidate, ketamine and midazolam on several bactericidal functions of polymorphonuclear leucocytes in vitro. Eur J Anaesthesiol 1995;12:141-6.
99. Gelb AW, Lok P. Etomidate reversibly depresses human neutrophil chemiluminescence. Anesthesiology 1987;66:60-3.
100. Szekely A, Heindl B, Zahler S, et al. Nonuniform behavior of intravenous anesthetics on postischemic adhesion of neutrophils in the guinea pig heart. Anesth Analg 2000;90:1293-300.
101. Weigand MA, Schmidt H, Zhao Q, et al. Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro. Anesth Analg 2000;90:206-12.
102. Reinke LA, Kotake Y, Moore DR, Nanji AA. Free radical formation during ketamine anesthesia in rats: a cautionary note. Free Radic Biol Med 1998;24:1002-6.
103. Tsuchiya M, Asada A, Maeda K, et al. Propofol versus midazolam regarding their antioxidant activities. Am J Respir Crit Care Med 2001;163:26-31.
104. Cheng YJ, Wang YP, Chien CT, Chen CF. Small-dose propofol sedation attenuates the formation of reactive oxygen species in tourniquet-induced ischemia-reperfusion injury under spinal anesthesia. Anesth Analg 2002;94:1617-20.
105. Nishina K, Akamatsu H, Mikawa K, et al. The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions. Anesth Analg 1998;86:159-65.
106. Kang MY, Tsuchiya M, Packer L, Manabe M. In vitro study on antioxidant potential of various drugs used in the perioperative period. Acta Anaesthesiol Scand 1998;42:4-12.
107. Ikeya K, Kashimoto S, Kume M, Kumazawa T. The influence of N-nitro-L-arginine methyl ester (L-NAME) on hydroxyl free radical formation in the post-ischemic reperfused heart of anesthetized rats. Masui J 2001;50:365-70.
108. Nakamura T, Kashimoto S, Oguchi T, Kumazawa T. Hydroxyl radical formation during inhalation anesthesia in the reperfused working rat heart. Can J Anaesth 1999;46:470-5.
109. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997;86:699-709.
110. ATP channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997;87:361-70.
111. Mullenheim J, Ebel D, Frabetadorf J, et al. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 2002;96:934-40.
112. Belhomme D, Peynet J, Louzy M, et al. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999;100:II340-4.
113. De Hert SG, Ten Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002;97:42-9.
114. Warltier D, Kersten JR, Pagel PS, Gross GJ. Editorial view: anesthetic preconditioning: serendipity and science. Anesthesiology 2002;97:1-3.
115. De Hert S, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetic: mechanism and clinical implications. Anesth Analg 2005;100:1584-93.
116. Novalija E, Kevin LG, Eells JT, et al. Anesthetic preconditioning improves ATP synthesis and reduces ROS formation in mitochondria after ischemia by a redox dependent mechanism. Anesthesiology 2003;98:1155-63.
117. Tanaka K, Weihrauch D, Kehl F, et al. Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 2002;97:1485-90.
118. Stowe DF, Kevin LG. Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics. Antiox Redox Signal 2004;6:439-48.
119. Park KW, Dai HB, Lowenstein E, et al. Oxygen-derived free radicals mediate isoflurane-induced vasoconstriction of rabbit coronary resistance arteries. Anesth Analg 1995;80:1163-7.
120. Yoshida K, Okabe E. Selective impairment of endothelium-dependent relaxation by sevoflurane: oxygen free radicals participation. Anesthesiology 1992;76:440-7.
121. Lind RC, Gandolfi AJ, Hall PD. The role of oxidative biotransformation of halothane in the guinea pig model of halothane-associated hepatotoxicity. Anesthesiology 1989;70:649-53.
122. Cohen PJ. Effect of anesthetics on mitochondrial function. Anesthesiology 1973;39:153-64.
123. Kissin I, Aultman DF, Smith LR. Effects of volatile anesthetics on myocardial oxidation-reduction status assessed by NADH fluorometry. Anesthesiology 1983;59:447-52.
124. Hanley PJ, Ray J, Brandt U, Daut J. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol 2002;544:687-93.
125. Riess ML, Novalija E, Camara AK, et al. Preconditioning with sevoflurane reduces changes in nicotinamide adenine dinucleotide during ischemia-reperfusion in isolated heart. Anesthesiology 2003;98:387-95.
126. Graham EV. The influence of ether and ether anesthesia on bacteriolysis, agglutination, and phagocytosis. J Infect Dis 1911;8:141-75.
127. Lieners C, Redl H, Schlag G, Hammerschmidt DE. Inhibition by halothane, but not by isoflurane, of oxidative response to opsonized zymosan in whole blood. Inflammation 1989;13:621-30.
128. 2+ mobilization in human neutrophils by halothane, enflurane, and isoflurane. Anesthesiology 1986;64:4-12.
129. Frohlich D, Rothe G, Schwall B, et al. Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide FMLP. Br J Anaesth 1997;78:718-23.
130. Frohlich D, Rothe G, Wittmann S, et al. Nitrous oxide impairs the neutrophil oxidative response. Anesthesiology 1998;88:1281-90.
131. Hu G, Vasiliauskas T, Salem MR, et al. Neutrophils pretreated with volatile anesthetics lose ability to cause cardiac dysfunction. Anesthesiology 2003;98:712-8.